헬스케어 BPO 시장 : 생명과학 분야별(Drug Discovery, 임상시험, 규제 대응), 의료 제공자별(RCM, 임상 문서, 환자 참여), 보험자별(청구, 보험금 청구), 기술별(BPaaS, AI 대응), 모델별(온쇼어, 오프쇼어) - 세계 예측(-2031년)

The global healthcare BPO market is projected to reach USD 735.05 billion by 2031, up from USD 459.83 billion in 2026, at a CAGR of 9.8%. Market growth is driven by the need to reduce operational pressure across payer, provider, and life sciences workflows. Healthcare organizations are outsourcing processes such as claims administration, member enrollment, provider network management, payment integrity, revenue cycle management, medical coding, patient support, clinical data management, pharmacovigilance, regulatory affairs, and commercialization support. Payers are using BPO partners to improve claims accuracy, reduce fraud and improper payments, manage provider data, and enhance member service.

Providers are outsourcing RCM, denial management, coding, documentation, and patient contact center operations to improve cash flow and reduce administrative workload. Life sciences companies are increasingly relying on outsourcing partners for clinical development, safety reporting, manufacturing support, supply chain, and regulatory operations because these activities require specialized expertise, compliance knowledge, and global delivery scale. The market is further supported by automation, AI-enabled coding, analytics-driven payment integrity, platform-based BPaaS, and offshore delivery models that help reduce costs and improve turnaround time.

"Manufacturing & packaging accounted for the largest share of the life science services segment in 2025"

Within life sciences services, the healthcare BPO market is segmented into research & clinical development, manufacturing & packaging, supply chain & logistics, commercialization and medical affairs, safety, regulatory & quality, and others. The manufacturing & packaging segment accounted for the largest share in 2025, as pharmaceutical, biotechnology, and medical device companies continue to outsource high-value production and packaging to specialized partners. This segment includes drug substance manufacturing, drug product manufacturing, biologics manufacturing, sterile fill-finish, device assembly, clinical and commercial packaging, labeling, and serialization. Outsourcing is especially important because life sciences companies need scalable manufacturing capacity, strict quality compliance, sterile production capabilities, and packaging support for regulated products.

"Payment integrity is expected to witness the fastest growth in payer services during the forecast period"

Based on payer services, the healthcare BPO market is segmented into member enrollment & billing, provider network management, claims administration, payment integrity, member & provider support, and others. Among these segments, payment integrity is expected to grow fastest over the forecast period. This growth is driven by the need to reduce improper payments, billing errors, duplicate claims, coding issues, fraud, waste, and abuse across payer operations. Payment integrity services include pre-payment review, post-payment audit, overpayment recovery, coordination of benefits, subrogation, claims coding review, clinical review, and fraud analytics. Payers are increasingly turning to outsourcing partners because claim rules, reimbursement contracts, provider billing patterns, and regulatory requirements are becoming more complex. As healthcare costs continue to rise, payment integrity is becoming a priority for health plans to protect margins, improve claims accuracy, and reduce avoidable medical spending.

"Asia Pacific to witness the fastest growth in the healthcare BPO market during the forecast period"

Asia Pacific is expected to see the highest growth rate in the healthcare BPO market over the forecast period. This growth is driven by rising healthcare digitization, expanding private healthcare networks, broader insurance coverage, and increased outsourcing of payer, provider, and life sciences processes. Countries such as India, China, Japan, South Korea, Australia, and the Philippines are becoming important markets as healthcare organizations seek to manage higher patient volumes, reduce administrative workloads, and improve claims, billing, medical coding, clinical data, and patient support operations. India's Ayushman Bharat Digital Mission is also building the digital infrastructure needed for connected health records and digital healthcare workflows, which can increase demand for technology-enabled outsourcing over time. Asia Pacific is also a strong delivery hub for healthcare BPO because of its large skilled workforce, cost-efficient operations, English-language support, and established outsourcing infrastructure. The Philippines IT-BPM industry was expected to reach USD 38 billion in revenue and 1.82 million jobs in 2024, according to Reuters in October 2024, underscoring the region's strong outsourcing base. In life sciences.

The breakdown of primary participants is as given below:

• By Company Type - Tier 1: 60%, Tier 2: 30%, and Tier 3: 10%
• By Designation - C-level: 30%, Director-level: 50%, and Others: 20%
• By Region - North America: 45%, Europe: 20%, Asia Pacific: 25%, Rest of the world: 10%.

Optum, Inc. (US), Tata Consultancy Services Limited (India), Accenture plc (Ireland), Cognizant (US), Infosys Limited (India), IQVIA Holdings Inc. (US) are some of the key players in the healthcare BPO market.

• The study includes an in-depth competitive analysis of these key players in the healthcare BPO market, with their company profiles, recent developments, and key market strategies.

Research Coverage

This research report categorizes the healthcare BPO market by Services: Life Sciences Services [Research & Clinical Development {Discovery & Preclinical, Clinical Trial Management, Clinical Data & Biostatistics, RWE & Late-Phase, Other R&D Support}, Manufacturing & Packaging, Supply Chain & Logistics, Commercialization and Medical Affairs, Safety, Regulatory & Quality, Others], Payer Services [Member Enrollment & Billing, Provider Network Management, Claims Administration {Claims Intake & Data Capture, Claims Adjudication & Settlement, Claims Editing, Pricing & Repricing, Claims Adjustment, Denials & Rework, Claims Payment & Remittance Support}, Payment Integrity, Member & Provider Support, Others], and Provider Services [Revenue Cycle Management {Front-end RCM, Mid-cycle RCM, Back-end RCM}, Health Information Management and Clinical Documentation {Clinical Documentation Improvement, Medical Transcription and Clinical Documentation Services, Medical Records Management and Release of Information}, Patient Engagement and Contact Center Services {Patient Contact Center and Communication Services, Patient Financial Counseling and Assistance, Post-discharge Follow-up and Care Navigation}, Clinical Support Services {Teleradiology and Remote Diagnostic Imaging Services, Remote Patient Monitoring Data Management, Population Health Outreach and Care Coordination Support}, Non-Clinical Administrative Support Services, Others]. The report also categorizes the market by Technology Model [Traditional BPO, Automation-enabled BPO, Platform-based BPaaS, AI-enabled BPO], Service Delivery Model [Onshore, Offshore, Hybrid/Multishore], and Region [North America, Europe, Asia Pacific, Latin America, and Middle East & Africa].

The report provides detailed information on major factors, including drivers, restraints, challenges, and opportunities, that influence the growth of the healthcare BPO market. A detailed analysis of key industry players has been conducted to provide insights into their business overviews, service portfolios, technological capabilities, key strategies, contracts, partnerships, agreements, service launches, mergers & acquisitions, and recent developments associated with the healthcare BPO market. The report also covers a competitive analysis of established and emerging players in the healthcare BPO ecosystem.

Reasons to buy this report

The report will provide market leaders and new entrants with the closest approximations of revenue figures for the healthcare BPO market and its subsegments. It will help stakeholders understand the competitive landscape and gain insights to position their businesses more effectively and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

• The report provides insights into the following factors influencing the growth of the healthcare BPO market: drivers (shift to ICD-10 coding standards and the upcoming ICD-11 standard, pressure to reduce rising healthcare costs, loss of revenue due to billing errors, demand for niche services, need for structured processes and documentation, lack of in-house expertise in end-use industries, and growing outsourcing in the pharma and biopharma industries), restraints (hidden outsourcing costs and concerns about losing visibility and control over business processes), opportunities (advanced data analytics and growing adoption of artificial intelligence-based tools for drug discovery), and challenges (limitations in the data capture process in Medicaid services and data security concerns).
• Product Development/Innovation: Detailed insights into upcoming technologies, research & development activities, and new product & service launches in the healthcare BPO market
• Market Development: Comprehensive information about lucrative markets; the report analyzes the healthcare BPO market across varied regions
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the healthcare BPO market
• Competitive Assessment: In-depth assessment of market share, growth strategies, and service offerings of leading players such as Optum, Inc. (US), Tata Consultancy Services Limited (India), Accenture plc (Ireland), Cognizant (US), Infosys Limited (India), IQVIA Holdings Inc. (US), among others, in the healthcare BPO market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION
  • 1.3.2 REGIONAL SCOPE
  • 1.3.3 INCLUSIONS AND EXCLUSIONS
  • 1.3.4 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 LIMITATIONS
• 1.6 STAKEHOLDERS
• 1.7 SUMMARY OF CHANGES

2 EXECUTIVE SUMMARY

• 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
• 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
• 2.3 DISRUPTIVE TRENDS IN HEALTHCARE BPO MARKET
• 2.4 HIGH-GROWTH SEGMENTS
• 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

• 3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN HEALTHCARE BPO MARKET
• 3.2 HEALTHCARE BPO MARKET, BY SERVICE AND REGION
• 3.3 HEALTHCARE BPO MARKET, BY TECHNOLOGY MODEL
• 3.4 HEALTHCARE BPO MARKET, BY SERVICE DELIVERY MODEL
• 3.5 HEALTHCARE BPO MARKET, BY GEOGRAPHY

4 MARKET OVERVIEW

• 4.1 INTRODUCTION
• 4.2 MARKET DYNAMICS
  • 4.2.1 DRIVERS
    • 4.2.1.1 Widespread ICD-10 adoption and transition to ICD-11 coding standards
    • 4.2.1.2 Rising need to cut healthcare costs while improving operational efficiency
    • 4.2.1.3 Growing concern about billing errors, coding inaccuracies, and claim denials
    • 4.2.1.4 Mounting demand for value-based care and evolving reimbursement models
    • 4.2.1.5 Rising emphasis on structured processes and documentation
    • 4.2.1.6 Increasing healthcare operation complexity and specialized professional shortage
    • 4.2.1.7 Strong focus on improving efficiency and safety in pharma and biopharma industries
  • 4.2.2 RESTRAINTS
    • 4.2.2.1 Implementation and governance cost burden
    • 4.2.2.2 Concerns related to visibility and control over business processes
  • 4.2.3 OPPORTUNITIES
    • 4.2.3.1 Reliance on advanced data analytics
    • 4.2.3.2 Rise in adoption of AI-based tools for drug discovery
  • 4.2.4 CHALLENGES
    • 4.2.4.1 Limitations in data capturing process in Medicaid services
    • 4.2.4.2 Data security concerns
• 4.3 UNMET NEEDS AND WHITE SPACES
• 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES
• 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

• 5.1 PORTER'S FIVE FORCES ANALYSIS
  • 5.1.1 THREAT OF NEW ENTRANTS
  • 5.1.2 THREAT OF SUBSTITUTES
  • 5.1.3 BARGAINING POWER OF SUPPLIERS
  • 5.1.4 BARGAINING POWER OF BUYERS
  • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.2 MACROECONOMICS OUTLOOK
  • 5.2.1 INTRODUCTION
  • 5.2.2 GDP TRENDS AND FORECAST
  • 5.2.3 TRENDS IN GLOBAL HEALTHCARE IT INDUSTRY
  • 5.2.4 TRENDS IN GLOBAL BUSINESS PROCESS OUTSOURCING INDUSTRY
• 5.3 SUPPLY CHAIN ANALYSIS
• 5.4 ECOSYSTEM ANALYSIS
• 5.5 PRICING ANALYSIS
  • 5.5.1 INDICATIVE PRICE OF HEALTHCARE BPO SERVICES, BY SERVICE TYPE, 2025
  • 5.5.2 INDICATIVE PRICE OF HEALTHCARE BPO SERVICES, BY REGION, 2025
• 5.6 KEY CONFERENCES AND EVENTS, 2026-2027
• 5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 5.8 INVESTMENT AND FUNDING SCENARIO
• 5.9 CASE STUDY ANALYSIS
  • 5.9.1 BIOPHARMACEUTICAL COMPANY IN US LEVERAGES CANON BUSINESS PROCESS SERVICES' ACCOUNTS PAYABLE OUTSOURCING SOLUTIONS TO OPTIMIZE END-TO-END INVOICE PROCESSING
  • 5.9.2 PHARMACEUTICAL COMPANY IN US RELIES ON C3I SOLUTIONS' MEDICAL INFORMATION OUTSOURCING SERVICES TO OPTIMIZE COST AND EFFICIENCIES
  • 5.9.3 RADIOLOGISTS IN AUSTRALIA ADOPT FLATWORLD SOLUTIONS' TRANSCRIPTION AUTOMATION OUTSOURCING SERVICES TO FOCUS ON PATIENT CARE
• 5.10 IMPACT OF US TARIFFS - HEALTHCARE BPO MARKET
  • 5.10.1 INTRODUCTION
  • 5.10.2 KEY TARIFF RATES
  • 5.10.3 PRICE IMPACT ANALYSIS
  • 5.10.4 IMPACT ON COUNTRIES/REGIONS
    • 5.10.4.1 US
    • 5.10.4.2 Europe
    • 5.10.4.3 Asia Pacific
• 5.11 IMPACT ON END USERS

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

• 6.1 KEY EMERGING TECHNOLOGIES
  • 6.1.1 ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING
  • 6.1.2 ROBOTIC PROCESS AUTOMATION
  • 6.1.3 CLOUD COMPUTING
• 6.2 COMPLEMENTARY TECHNOLOGIES
  • 6.2.1 WEARABLE DEVICES AND REMOTE MONITORING TOOLS
  • 6.2.2 AUGMENTED REALITY AND VIRTUAL REALITY
  • 6.2.3 DATA ANALYTICS AND BUSINESS INTELLIGENCE
• 6.3 ADJACENT TECHNOLOGIES
  • 6.3.1 NATURAL LANGUAGE PROCESSING
  • 6.3.2 INTERNET OF MEDICAL THINGS
  • 6.3.3 BLOCKCHAIN
• 6.4 TECHNOLOGY/PRODUCT ROADMAP
• 6.5 PATENT ANALYSIS
  • 6.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE BPO
  • 6.5.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
• 6.6 FUTURE APPLICATIONS
  • 6.6.1 AGENTIC AI AND AUTONOMOUS HEALTHCARE OPERATIONS
  • 6.6.2 PREDICTIVE POPULATION HEALTH AND PERSONALIZED PATIENT ENGAGEMENT
  • 6.6.3 REAL-WORLD DATA AND LIFE SCIENCES SUPPORT SERVICES
• 6.7 IMPACT OF AI/GEN AI ON HEALTHCARE BPO MARKET
  • 6.7.1 TOP USE CASES AND MARKET POTENTIAL
  • 6.7.2 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION IN HEALTHCARE BPO MARKET
  • 6.7.3 INTERCONNECTED ECOSYSTEMS AND IMPACT ON MARKET PLAYERS
  • 6.7.4 CLIENTS' READINESS TO ADOPT AI/GEN AI IN HEALTHCARE BPO MARKET
    • 6.7.4.1 User readiness
      • 6.7.4.1.1 User A: Healthcare payers (health plans & insurance companies)
      • 6.7.4.1.2 User B: Healthcare providers (hospitals, health systems & physician groups)
    • 6.7.4.2 Impact assessment
      • 6.7.4.2.1 User A
        • 6.7.4.2.1.1 Implementation
        • 6.7.4.2.1.2 Impact
      • 6.7.4.2.2 User B
        • 6.7.4.2.2.1 Implementation
        • 6.7.4.2.2.2 Impact
  • 6.7.5 BEST PRACTICES FOLLOWED BY COMPANIES IN HEALTHCARE BPO MARKET

7 REGULATORY LANDSCAPE

• 7.1 REGIONAL REGULATIONS AND COMPLIANCE
  • 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 7.1.2 REGULATIONS
  • 7.1.3 INDUSTRY STANDARDS

8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR

• 8.1 INTRODUCTION
• 8.2 DECISION-MAKING PROCESS
• 8.3 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS AND EVALUATION CRITERIA
  • 8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 8.3.2 BUYING CRITERIA
• 8.4 ADOPTION BARRIERS AND INTERNAL CHALLENGES
• 8.5 UNMET NEEDS OF VARIOUS END USERS
  • 8.5.1 UNMET NEEDS
  • 8.5.2 END USERS' EXPECTATIONS
• 8.6 MARKET PROFITABILITY

9 HEALTHCARE BPO MARKET, BY SERVICE

• 9.1 INTRODUCTION
• 9.2 LIFE SCIENCES SERVICES
  • 9.2.1 RESEARCH & CLINICAL DEVELOPMENT
    • 9.2.1.1 Discovery & preclinical
      • 9.2.1.1.1 Growing demand for specialized capabilities and operational agility to foster segmental growth
    • 9.2.1.2 Clinical trial management
      • 9.2.1.2.1 Rising operational complexity of decentralized and hybrid trial models to augment segmental growth
    • 9.2.1.3 Clinical data & biostatistics
      • 9.2.1.3.1 High emphasis on data quality, regulatory compliance, and risk-based quality management to expedite segmental growth
    • 9.2.1.4 RWE & late-phase
      • 9.2.1.4.1 Growing focus on meeting evolving regulatory, market access, and reimbursement requirements to fuel segmental growth
    • 9.2.1.5 Other R&D services
  • 9.2.2 MANUFACTURING & PACKAGING
    • 9.2.2.1 Mounting demand for biologics, GLP-1 therapies, cell and gene therapies, and other complex biopharmaceutical products to drive market
  • 9.2.3 SUPPLY CHAIN & LOGISTICS
    • 9.2.3.1 Rising real-time data exchange and electronic drug traceability requirements to contribute to segmental growth
  • 9.2.4 COMMERCIALIZATION & MEDICAL AFFAIRS
    • 9.2.4.1 Increasing complexity of pricing, reimbursement, health economics, and value-based healthcare to boost segmental growth
  • 9.2.5 SAFETY, REGULATORY & QUALITY
    • 9.2.5.1 Growing volume of adverse event and post-marketing surveillance obligations to accelerate segmental growth
  • 9.2.6 OTHER LIFE SCIENCES SERVICES
• 9.3 PAYER SERVICES
  • 9.3.1 MEMBER ENROLLMENT & BILLING
    • 9.3.1.1 Rapid expansion of health plans, frequent eligibility redeterminations, and changing member coverage to drive market
  • 9.3.2 PROVIDER NETWORK MANAGEMENT
    • 9.3.2.1 Stricter network adequacy and directory accuracy standards to bolster segmental growth
  • 9.3.3 CLAIMS ADMINISTRATION
    • 9.3.3.1 Claims intake & data capture
      • 9.3.3.1.1 Mounting adoption of digital technologies to improve data accuracy to expedite segmental growth
    • 9.3.3.2 Claims adjudication & settlement
      • 9.3.3.2.1 Increasing complexity of reimbursement policies to create market growth opportunities
    • 9.3.3.3 Claims editing, pricing & repricing
      • 9.3.3.3.1 Rising deployment of technology-enabled solutions to streamline processes to foster segmental growth
    • 9.3.3.4 Claims adjustment, denials & rework
      • 9.3.3.4.1 Evolving reimbursement policies and increasing regulatory requirements to augment segmental growth
    • 9.3.3.5 Claims payment & remittance support
      • 9.3.3.5.1 Growing emphasis on payment integrity, dispute resolution, and regulatory compliance to fuel segmental growth
  • 9.3.4 PAYMENT INTEGRITY
    • 9.3.4.1 Increasing reliance on specialized service providers to reduce fraud to facilitate segmental growth
  • 9.3.5 MEMBER & PROVIDER SUPPORT
    • 9.3.5.1 Rising adoption of omnichannel customer engagement models to enhance member experience to expedite segmental growth
  • 9.3.6 OTHER PAYER SERVICES
• 9.4 PROVIDER SERVICES
  • 9.4.1 REVENUE CYCLE MANAGEMENT (RCM)
    • 9.4.1.1 Front-end RCM
      • 9.4.1.1.1 Rising enrollment in high-deductible health plans and evolving prior authorization requirements to drive market
    • 9.4.1.2 Mid-cycle RCM
      • 9.4.1.2.1 Increasing shortage of certified medical coders, documentation requirements, and heightened payer scrutiny to fuel segmental growth
    • 9.4.1.3 Back-end RCM
      • 9.4.1.3.1 Strong focus on improving claims resolution, reimbursement, and accounts receivable performance to spur demand
  • 9.4.2 HEALTH INFORMATION MANAGEMENT (HIM) & CLINICAL DOCUMENTATION
    • 9.4.2.1 Clinical documentation improvement (CDI)
      • 9.4.2.1.1 Rising regulatory scrutiny and emphasis on accurate diagnosis to contribute to segmental growth
    • 9.4.2.2 Medical transcription & clinical documentation services
      • 9.4.2.2.1 Increasing reliance on ambient AI, speech recognition, and automated technologies to augment segmental growth
    • 9.4.2.3 Medical records management & release of information (ROI)
      • 9.4.2.3.1 Evolving cybersecurity requirements and emphasis on secure health information exchange to drive market
  • 9.4.3 PATIENT ENGAGEMENT & CONTACT CENTER SERVICES
    • 9.4.3.1 Patient contact center & communication
      • 9.4.3.1.1 Rising patient expectations, call volumes, and workforce shortages to bolster segmental growth
    • 9.4.3.2 Patient financial counseling & assistance
      • 9.4.3.2.1 Increasing enrollment in high-deductible health plans and out-of-pocket healthcare expenses to fuel segmental growth
    • 9.4.3.3 Post-discharge follow-up & care navigation
      • 9.4.3.3.1 Strong focus on improving care continuity, patient outcomes, and value-based healthcare delivery to expedite segmental growth
  • 9.4.4 CLINICAL SUPPORT SERVICES
    • 9.4.4.1 Teleradiology & remote diagnostic imaging
      • 9.4.4.1.1 Rising need to improve diagnostic turnaround times and overcome persistent radiologist shortages to drive market
    • 9.4.4.2 Remote patient monitoring (RPM) data management
      • 9.4.4.2.1 Growing emphasis on reducing operational costs and improving care efficiency to accelerate segmental growth
    • 9.4.4.3 Population health outreach & care coordination support
      • 9.4.4.3.1 Increasing focus on direct patient care while supporting performance under value-based contracts to fuel segmental growth
  • 9.4.5 NON-CLINICAL ADMINISTRATIVE SUPPORT SERVICES
    • 9.4.5.1 Persistent workforce shortages and rising operational costs to augment segmental growth
  • 9.4.6 OTHER PROVIDER SERVICES

10 HEALTHCARE BPO MARKET, BY TECHNOLOGY MODEL

• 10.1 INTRODUCTION
• 10.2 TRADITIONAL BPO
  • 10.2.1 INCREASING COMPLEX, JUDGMENT-INTENSIVE PROCESSES TO BOLSTER SEGMENTAL GROWTH
• 10.3 AUTOMATION-ENABLED BPO
  • 10.3.1 STRONG FOCUS ON IMPROVING PROCESSING SPEED, ENHANCING ACCURACY, AND LOWERING OPERATIONAL COSTS TO SPUR DEMAND
• 10.4 PLATFORM-BASED BPAAS
  • 10.4.1 MOUNTING ADOPTION OF CLOUD-BASED, OUTCOME-DRIVEN TECHNOLOGIES TO FOSTER SEGMENTAL GROWTH
• 10.5 AI-ENABLED BPO
  • 10.5.1 RAPID ADVANCES IN GEN AI, MACHINE LEARNING, NATURAL LANGUAGE PROCESSING, AND INTELLIGENT AUTOMATION TO EXPEDITE SEGMENTAL GROWTH

11 HEALTHCARE BPO MARKET, BY SERVICE DELIVERY MODEL

• 11.1 INTRODUCTION
• 11.2 ONSHORE
  • 11.2.1 EVOLVING HEALTHCARE DATA PRIVACY REGULATIONS AND CYBERSECURITY REQUIREMENTS TO FOSTER SEGMENTAL GROWTH
• 11.3 OFFSHORE
  • 11.3.1 ABILITY TO PROVIDE COST-EFFICIENT, SCALABLE SERVICES THROUGH SKILLED HEALTHCARE PROFESSIONALS TO BOOST SEGMENTAL GROWTH
• 11.4 HYBRID/MULTISHORE
  • 11.4.1 FOCUS ON OPTIMIZING COST, QUALITY, REGULATORY COMPLIANCE, AND OPERATIONAL RESILIENCE TO AUGMENT SEGMENTAL GROWTH

12 HEALTHCARE BPO MARKET, BY REGION

• 12.1 INTRODUCTION
• 12.2 NORTH AMERICA
  • 12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 12.2.2 US
    • 12.2.2.1 Rising administrative costs, complex regulatory environment, and demand for operational efficiency to fuel market growth
  • 12.2.3 CANADA
    • 12.2.3.1 Increasing healthcare digitalization and need for administrative efficiency to bolster market growth
• 12.3 EUROPE
  • 12.3.1 GERMANY
    • 12.3.1.1 Ongoing healthcare financing reforms and digital transformation to contribute to market growth
  • 12.3.2 FRANCE
    • 12.3.2.1 Increasing investment in digital health infrastructure to accelerate market growth
  • 12.3.3 UK
    • 12.3.3.1 Growing operational pressures and digital maturity requirements to foster market growth
  • 12.3.4 ITALY
    • 12.3.4.1 Rising healthcare digitization funding to modernize hospital IT infrastructure to drive market
  • 12.3.5 SPAIN
    • 12.3.5.1 Accelerating healthcare digitization and interoperability mandates to expedite market growth
  • 12.3.6 REST OF EUROPE
• 12.4 ASIA PACIFIC
  • 12.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 12.4.2 CHINA
    • 12.4.2.1 Strong focus on developing smart hospitals to bolster market growth
  • 12.4.3 JAPAN
    • 12.4.3.1 Rapid standardization of electronic claims and medical-record exchange to support market growth
  • 12.4.4 INDIA
    • 12.4.4.1 Increasing digital health initiatives and standardized electronic claims infrastructure to create market growth opportunities
  • 12.4.5 AUSTRALIA
    • 12.4.5.1 Rising regulatory changes, healthcare digitization, and increasing administrative complexity to drive market
  • 12.4.6 SOUTH KOREA
    • 12.4.6.1 Mounting adoption of AI-based and digital health products to facilitate market growth
  • 12.4.7 REST OF ASIA PACIFIC
• 12.5 LATIN AMERICA
  • 12.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 12.5.2 BRAZIL
    • 12.5.2.1 Evolving regulatory standards and private health insurance sector to foster market growth
  • 12.5.3 MEXICO
    • 12.5.3.1 Increasing rollout of digital health credentials to consolidate access to fragmented public health institutions to drive market
  • 12.5.4 REST OF LATIN AMERICA
• 12.6 MIDDLE EAST & AFRICA
  • 12.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 12.6.2 GCC COUNTRIES
    • 12.6.2.1 Saudi Arabia
      • 12.6.2.1.1 Rapid transformation of healthcare payment models to accelerate market growth
    • 12.6.2.2 UAE
      • 12.6.2.2.1 Rising claim values due to extension of mandatory health insurance to boost market growth
    • 12.6.2.3 Rest of GCC
  • 12.6.3 SOUTH AFRICA
    • 12.6.3.1 Increasing investment in outsourced digital-engagement and claims-analytics to expedite market growth
  • 12.6.4 REST OF MIDDLE EAST & AFRICA

13 COMPETITIVE LANDSCAPE

• 13.1 OVERVIEW
• 13.2 KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, 2023-2026
• 13.3 REVENUE ANALYSIS, 2021-2025
• 13.4 MARKET SHARE ANALYSIS, 2025
• 13.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
  • 13.5.1 STARS
  • 13.5.2 EMERGING LEADERS
  • 13.5.3 PERVASIVE PLAYERS
  • 13.5.4 PARTICIPANTS
  • 13.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
    • 13.5.5.1 Company footprint
    • 13.5.5.2 Region footprint
    • 13.5.5.3 Service footprint
    • 13.5.5.4 Technology model footprint
    • 13.5.5.5 Service delivery model footprint
• 13.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
  • 13.6.1 PROGRESSIVE COMPANIES
  • 13.6.2 RESPONSIVE COMPANIES
  • 13.6.3 DYNAMIC COMPANIES
  • 13.6.4 STARTING BLOCKS
  • 13.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
    • 13.6.5.1 Detailed list of key startups/SMEs
    • 13.6.5.2 Competitive benchmarking of key startups/SMEs
• 13.7 COMPANY VALUATION AND FINANCIAL METRICS
• 13.8 BRAND/SOFTWARE COMPARISON
  • 13.8.1 OPTUM, INC. (US)
  • 13.8.2 ACCENTURE PLC (IRELAND)
  • 13.8.3 COGNIZANT (US)
  • 13.8.4 CAPGEMINI SE (FRANCE)
  • 13.8.5 TATA CONSULTANCY SERVICES LIMITED (INDIA)
• 13.9 COMPETITIVE SCENARIO
  • 13.9.1 PRODUCT/SERVICE LAUNCHES
  • 13.9.2 DEALS
  • 13.9.3 EXPANSIONS

14 COMPANY PROFILES

• 14.1 KEY PLAYERS
  • 14.1.1 OPTUM, INC.
    • 14.1.1.1 Business overview
    • 14.1.1.2 Products/Services offered
    • 14.1.1.3 Recent developments
      • 14.1.1.3.1 Product/Service launches
      • 14.1.1.3.2 Deals
    • 14.1.1.4 MnM view
      • 14.1.1.4.1 Key strengths/Right to win
      • 14.1.1.4.2 Strategic choices
      • 14.1.1.4.3 Weaknesses/Competitive threats
  • 14.1.2 ACCENTURE PLC
    • 14.1.2.1 Business overview
    • 14.1.2.2 Products/Services offered
    • 14.1.2.3 Recent developments
      • 14.1.2.3.1 Deals
    • 14.1.2.4 MnM view
      • 14.1.2.4.1 Key strengths/Right to win
      • 14.1.2.4.2 Strategic choices
      • 14.1.2.4.3 Weaknesses/Competitive threats
  • 14.1.3 TATA CONSULTANCY SERVICES LIMITED
    • 14.1.3.1 Business overview
    • 14.1.3.2 Products/Services offered
    • 14.1.3.3 Recent developments
      • 14.1.3.3.1 Product/Service launches
      • 14.1.3.3.2 Deals
    • 14.1.3.4 MnM view
      • 14.1.3.4.1 Key strengths/Right to win
      • 14.1.3.4.2 Strategic choices
      • 14.1.3.4.3 Weaknesses/Competitive threats
  • 14.1.4 COGNIZANT
    • 14.1.4.1 Business overview
    • 14.1.4.2 Products/Services offered
    • 14.1.4.3 Recent developments
      • 14.1.4.3.1 Product/Service launches
      • 14.1.4.3.2 Deals
    • 14.1.4.4 MnM view
      • 14.1.4.4.1 Key strengths/Right to win
      • 14.1.4.4.2 Strategic choices
      • 14.1.4.4.3 Weaknesses/Competitive threats
  • 14.1.5 CAPGEMINI SE
    • 14.1.5.1 Business overview
    • 14.1.5.2 Products/Services offered
    • 14.1.5.3 Recent developments
      • 14.1.5.3.1 Deals
      • 14.1.5.3.2 Expansions
    • 14.1.5.4 MnM view
      • 14.1.5.4.1 Key strengths/Right to win
      • 14.1.5.4.2 Strategic choices
      • 14.1.5.4.3 Weaknesses/Competitive threats
  • 14.1.6 INFOSYS LIMITED
    • 14.1.6.1 Business overview
    • 14.1.6.2 Products/Services offered
    • 14.1.6.3 Recent developments
      • 14.1.6.3.1 Deals
  • 14.1.7 IQVIA HOLDINGS INC.
    • 14.1.7.1 Business overview
    • 14.1.7.2 Products/Services offered
    • 14.1.7.3 Recent developments
      • 14.1.7.3.1 Product/Service launches
      • 14.1.7.3.2 Deals
  • 14.1.8 WIPRO LIMITED
    • 14.1.8.1 Business overview
    • 14.1.8.2 Products/Services offered
    • 14.1.8.3 Recent developments
      • 14.1.8.3.1 Deals
  • 14.1.9 NTT DATA GROUP CORPORATION
    • 14.1.9.1 Business overview
    • 14.1.9.2 Products/Services offered
    • 14.1.9.3 Recent developments
      • 14.1.9.3.1 Deals
      • 14.1.9.3.2 Expansions
  • 14.1.10 HCL TECHNOLOGIES LIMITED
    • 14.1.10.1 Business overview
    • 14.1.10.2 Products/Services offered
    • 14.1.10.3 Recent developments
      • 14.1.10.3.1 Deals
  • 14.1.11 GENPACT LIMITED
    • 14.1.11.1 Business overview
    • 14.1.11.2 Products/Services offered
    • 14.1.11.3 Recent developments
      • 14.1.11.3.1 Product/Service launches
      • 14.1.11.3.2 Deals
  • 14.1.12 EXLSERVICE HOLDINGS, INC.
    • 14.1.12.1 Business overview
    • 14.1.12.2 Products/Services offered
    • 14.1.12.3 Recent developments
      • 14.1.12.3.1 Deals
  • 14.1.13 SAGILITY LIMITED
    • 14.1.13.1 Business overview
    • 14.1.13.2 Products/Services offered
    • 14.1.13.3 Recent developments
      • 14.1.13.3.1 Deals
  • 14.1.14 FIRSTSOURCE SOLUTIONS LIMITED
    • 14.1.14.1 Business overview
    • 14.1.14.2 Products/Services offered
    • 14.1.14.3 Recent developments
      • 14.1.14.3.1 Product/Service launches
      • 14.1.14.3.2 Deals
  • 14.1.15 CONDUENT INCORPORATED
    • 14.1.15.1 Business overview
    • 14.1.15.2 Products/Services offered
    • 14.1.15.3 Recent developments
      • 14.1.15.3.1 Deals
      • 14.1.15.3.2 Other developments
  • 14.1.16 COTIVITI, INC.
    • 14.1.16.1 Business overview
    • 14.1.16.2 Products/Services offered
    • 14.1.16.3 Recent developments
      • 14.1.16.3.1 Deals
      • 14.1.16.3.2 Expansions
  • 14.1.17 R1 RCM INC.
    • 14.1.17.1 Business overview
    • 14.1.17.2 Products/Services offered
    • 14.1.17.3 Recent developments
      • 14.1.17.3.1 Product/Service launches
      • 14.1.17.3.2 Deals
      • 14.1.17.3.3 Other developments
  • 14.1.18 AGS HEALTH
    • 14.1.18.1 Business overview
    • 14.1.18.2 Products/Services offered
    • 14.1.18.3 Recent developments
      • 14.1.18.3.1 Product/Service launches
      • 14.1.18.3.2 Deals
      • 14.1.18.3.3 Expansions
  • 14.1.19 OMEGA HEALTHCARE MANAGEMENT SERVICES
    • 14.1.19.1 Business overview
    • 14.1.19.2 Products/Services offered
    • 14.1.19.3 Recent developments
      • 14.1.19.3.1 Deals
  • 14.1.20 GEBBS HEALTHCARE SOLUTIONS, INC.
    • 14.1.20.1 Business overview
    • 14.1.20.2 Products/Services offered
    • 14.1.20.3 Recent developments
      • 14.1.20.3.1 Deals
      • 14.1.20.3.2 Other developments
• 14.2 OTHER PLAYERS
  • 14.2.1 AKASA, INC.
  • 14.2.2 CODAMETRIX, INC.
  • 14.2.3 THOUGHTFUL AUTOMATION INC.
  • 14.2.4 ADONIS TECHNOLOGY, INC.
  • 14.2.5 RAPIDCLAIMS

15 RESEARCH METHODOLOGY

• 15.1 RESEARCH APPROACH
  • 15.1.1 SECONDARY RESEARCH
    • 15.1.1.1 List of key secondary sources
    • 15.1.1.2 Key data from secondary sources
  • 15.1.2 PRIMARY RESEARCH
    • 15.1.2.1 List of primary interview participants
    • 15.1.2.2 Key data from primary sources
    • 15.1.2.3 Breakdown of primary interviews
    • 15.1.2.4 Insights from primary experts
• 15.2 RESEARCH METHODOLOGY DESIGN
• 15.3 MARKET SIZE ESTIMATION
  • 15.3.1 BOTTOM-UP APPROACH
  • 15.3.2 TOP-DOWN APPROACH
• 15.4 DATA TRIANGULATION
• 15.5 RESEARCH ASSUMPTIONS
• 15.6 RESEARCH LIMITATIONS
• 15.7 RISK ANALYSIS

16 APPENDIX

• 16.1 DISCUSSION GUIDE
• 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 16.3 CUSTOMIZATION OPTIONS
• 16.4 RELATED REPORTS
• 16.5 AUTHOR DETAILS